U.S., China discuss medicine
This article was originally published in The Tan Sheet
The signing of a memorandum of understanding "to foster collaboration between scientists in both countries" in researching integrative and traditional Chinese medicine kicks-off a two-day roundtable discussion of traditional Chinese medicine, according to a June 16 release. Roundtable participants, including Health and Human Services Secretary Mike Leavitt, NIH scientists and the Chinese State Administration led by Vice Minister of Health Wang Guoqiang, discussed criteria to evaluate traditional Chinese medicine practices, the synthesis of Western and traditional Chinese medicine and the application of modern scientific tools to traditional Chinese medicine. In October 2007, Coca-Cola opened a research center in Beijing focused on locally sourced traditional Chinese herbs and formulas that the food and beverage giant plans to use for products it will offer worldwide (1"The Tan Sheet" Nov. 5, 2007, p. 14)...
You may also be interested in...
Coca-Cola preceded the opening of its first research center in China with extensive research on locally sourced traditional Chinese herbs and formulas, which it plans to use for products it will offer worldwide, the Atlanta-based beverage giant said Oct. 14
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.